Predictive factors of persistent thrombocytopenia after 177Lu-DOTATATE in patients with neuroendocrine tumors

被引：0
|
作者：
Oziel-Taieb, S. [1 ]
Ferrara, R. [1 ]
Charrier, N. [1 ]
Maniry, J. [1 ]
Reichert, T. [1 ]
Brenot-Rossi, I [1 ]
Niccoli, P. [1 ]
机构：
[1] IPC Net Ctr, ENETS Ctr Excellence, Paoli Calmettes Inst, Marseille, France
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2024年 / 36卷
关键词：
neuroendocrine tumor; prrt; ludotatate; thrombocytopenia; bone metastasis; spleen;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H16
引用
收藏
页码：213 / 213
页数：1
相关论文
共 50 条
  • [1] Rapid Progression After 177Lu-DOTATATE in Patients With Neuroendocrine Tumors
    Assi, Hussein A.
    Hornbacker, Kathleen
    Shaheen, Shagufta
    Wittenberg, Theresa
    Silberman, Robyn
    Kunz, Pamela L.
    PANCREAS, 2021, 50 (06) : 890 - 894
  • [2] 177Lu-Dotatate for Midgut Neuroendocrine Tumors
    Ozdemir, Nuriye Y.
    Arslan, Suheyla A.
    Sendur, Mehmet A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (14): : 1391 - 1391
  • [3] Prognostic factors in patients with advanced neuroendocrine tumors treated with 177Lu-DOTATATE
    Casanovas, M. Mitjavila
    Percovich, J.
    Bello, P.
    Arbizu, J.
    Pubul, V.
    Riesco, M.
    Muros, M.
    Gonzalez, E.
    Carmona-Bayonas, A.
    Estenoz, J.
    Rotger, A.
    Llana, B.
    Aller, J.
    Jimenez-Fonseca, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S593 - S594
  • [4] 177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors
    Das, Satya
    Al-Toubah, Taymeyah
    El-Haddad, Ghassan
    Strosberg, Jonathan
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (11) : 1023 - 1031
  • [5] Evaluation of 177Lu-Dotatate treatment in patients with metastatic neuroendocrine tumors and prognostic factors
    Abou Jokh Casas, Estephany
    Pubul Nunez, Virginia
    Anido-Herranz, Urbano
    Mallon Araujo, Maria del Carmen
    Pombo Pasin, Maria del Carmen
    Pumar, Miguel Garrido
    Cabezas Agricola, Jose Manuel
    Manuel Cameselle-Teijeiro, Jose
    Hilal, Ashraf
    Ruibal Morell, Alvaro
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (13) : 1513 - 1524
  • [6] Evaluation of 177Lu-Dotatate treatment in patients with metastatic neuroendocrine tumors and prognostic factors
    Estephany Abou Jokh Casas
    Virginia Pubul Nú?ez
    Urbano Anido-Herranz
    María del Carmen Mallón Araujo
    Maria del Carmen Pombo Pasín
    Miguel Garrido Pumar
    José Manuel Cabezas Agrícola
    José Manuel Cameselle-Teijeiro
    Ashraf Hilal
    álvaro Ruibal Morell
    World Journal of Gastroenterology, 2020, 26 (13) : 1513 - 1524
  • [7] Toxicity evaluation of 177Lu-DOTATATE for advanced neuroendocrine tumors
    Bonilla Plaza, J.
    Martinez Lorca, A.
    Navarro Martinez, T.
    Ajuria Illarramendi, O.
    Lopez Villar, I.
    Azpeitia Hernandez, P.
    Gutierrez Guerrero, M.
    Paredes Rodriguez, P.
    Orduna Diez, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S471 - S471
  • [8] Dosimetric studies of 177Lu-DOTATATE administered into neuroendocrine tumors
    Gupta, Santosh
    Singla, Suhas
    Chakraborty, Sudipta
    Banerjee, Sharmila
    Das, Tapas
    Venkatesh, Meera
    Bal, C.
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [9] Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE
    Strosberg, Jonathan R.
    Srirajaskanthan, Rajaventhan
    El-Haddad, Ghassan
    Wolin, Edward M.
    Chasen, Beth R.
    Kulke, Matthew H.
    Bushnell, David L.
    Caplin, Martyn E.
    Baum, Richard P.
    Hendifar, Andrew E.
    Oberg, Kjell
    Ruszniewski, Philippe
    Santoro, Paola
    Broberg, Per
    Leeuwenkamp, Oscar R.
    Krenning, Eric P.
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (12) : 1712 - 1718
  • [10] Therapeutic response evaluation in patients with neuroendocrine tumors treated with 177Lu-DOTATATE
    Gupta, Santosh
    Damle, Nishikant
    Bal, Chandrasekhar
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
12345